z-logo
open-access-imgOpen Access
Acute Promyelocytic Leukemia in Pediatric Population: A Rare Presentation
Author(s) -
Rabiah Asghar,
Javera Tariq,
Shahzad Ali Jiskani,
Sundas Ali,
Aneela Zafar
Publication year - 2020
Publication title -
national journal of health sciences
Language(s) - English
Resource type - Journals
eISSN - 2519-7878
pISSN - 2519-7053
DOI - 10.21089/njhs.52.0083
Subject(s) - acute promyelocytic leukemia , medicine , bone marrow , leukemia , myeloid leukemia , population , myeloid , tretinoin , pediatrics , gastroenterology , retinoic acid , biochemistry , chemistry , environmental health , gene
Acute Promyelocytic Leukemia (APL) is a very uncommon type of acute myeloid leukemiacomprising less than 10% of pediatric population. Acute Promyelocytic leukemia is a neoplastic proliferation of abnormal promyelocytes in bone marrow, caused by cytogenetic abnormality t(15;17). Majority of patients (80%) have long term survival, and death occurs in approximately 10% of patients in early course of the disease; mainly because of hemorrhage. Hemorrhagic complications can be reduced by appropriate therapy if started timely, which ultimately reduces the risk of death.We report a case of 7 years old boy with complaints of fever off and on for past 06 months, bruises and swelling on left leg for 1 week, blood containing vomiting for 1day. He was diagnosed as APL on bone marrow biopsy. Keywords: Acute promyelocytic leukemia, Paediatric, Retinoic acid syndrome, All-Trans retinoic acid, FAB AML-M3, Sudan Black-B.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom